The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pancreatic Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pancreatic Diseases


High impact information on Pancreatic Diseases


Chemical compound and disease context of Pancreatic Diseases


Biological context of Pancreatic Diseases


Anatomical context of Pancreatic Diseases


Gene context of Pancreatic Diseases


Analytical, diagnostic and therapeutic context of Pancreatic Diseases


  1. Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue. Rolfini, R., Cabrini, G. J. Clin. Invest. (1993) [Pubmed]
  2. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Schneider, A., Suman, A., Rossi, L., Barmada, M.M., Beglinger, C., Parvin, S., Sattar, S., Ali, L., Khan, A.K., Gyr, N., Whitcomb, D.C. Gastroenterology (2002) [Pubmed]
  3. Value of serum PABA as a pancreatic function test. Lang, C., Gyr, K., Tonko, I., Conen, D., Stalder, G.A. Gut (1984) [Pubmed]
  4. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Ohuchida, K., Mizumoto, K., Ishikawa, N., Fujii, K., Konomi, H., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., Tanaka, M. Clin. Cancer Res. (2005) [Pubmed]
  5. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Manfredi, R., Costamagna, G., Brizi, M.G., Maresca, G., Vecchioli, A., Colagrande, C., Marano, P. Radiology. (2000) [Pubmed]
  6. A prospective comparison of current diagnostic tests for pancreatic cancer. DiMagno, E.P., Malagelada, J.R., Taylor, W.F., Go, V.L. N. Engl. J. Med. (1977) [Pubmed]
  7. Human pancreatitis-associated protein. Messenger RNA cloning and expression in pancreatic diseases. Orelle, B., Keim, V., Masciotra, L., Dagorn, J.C., Iovanna, J.L. J. Clin. Invest. (1992) [Pubmed]
  8. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Means, A.L., Ray, K.C., Singh, A.B., Washington, M.K., Whitehead, R.H., Harris, R.C., Wright, C.V., Coffey, R.J., Leach, S.D. Gastroenterology (2003) [Pubmed]
  9. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Tada, M., Ohashi, M., Shiratori, Y., Okudaira, T., Komatsu, Y., Kawabe, T., Yoshida, H., Machinami, R., Kishi, K., Omata, M. Gastroenterology (1996) [Pubmed]
  10. PET with fluorine-18 deoxyglucose for pancreatic disease. Klever, P., Bares, R., Fass, J., Büll, U., Schumpelick, V. Lancet (1992) [Pubmed]
  11. Screening for pancreatic disease: A comparison of grey-scale ultrasonography and isotope scanning. Berger, L.A., Rhodes, J.M., Agnew, J.E., Horrocks, R.A., Chudleigh, P.M., Elias, E., Summerfield, J.A. Lancet (1979) [Pubmed]
  12. Total parenteral nutrition in pancreatic disease. Grant, J.P., James, S., Grabowski, V., Trexler, K.M. Ann. Surg. (1984) [Pubmed]
  13. Renal clearance of pancreatic and salivary amylase relative to creatinine in patients with chronic renal insufficiency. Keogh, J.B., McGeeney, K.F., Drury, M.I., Counihan, T.B., O'Donnell, M.D. Gut (1978) [Pubmed]
  14. Fatty acid ethyl ester synthase, an enzyme for nonoxidative ethanol metabolism, is present in serum after liver and pancreatic injury. Aleryani, S., Kabakibi, A., Cluette-Brown, J., Laposata, M. Clin. Chem. (1996) [Pubmed]
  15. Carbon-11-labeled amino acids for the rectilinear and positron tomographic imaging of the human pancreas. Hübner, K.F., Andrews, G.A., Buonocore, E., Hayes, R.L., Washburn, L.C., Collmann, I.R., Gibbs, W.D. J. Nucl. Med. (1979) [Pubmed]
  16. Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions. Klump, B., Hsieh, C.J., Nehls, O., Dette, S., Holzmann, K., Kiesslich, R., Jung, M., Sinn, U., Ortner, M., Porschen, R., Gregor, M. Br. J. Cancer (2003) [Pubmed]
  17. An evaluation of the low-pH enzymatic assay of urinary D-glucaric acid, and its use as a marker of enzyme induction in exocrine pancreatic disease. Sandle, L.N., Braganza, J.M. Clin. Chim. Acta (1987) [Pubmed]
  18. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Bartsch, H., Malaveille, C., Lowenfels, A.B., Maisonneuve, P., Hautefeuille, A., Boyle, P. Eur. J. Cancer Prev. (1998) [Pubmed]
  19. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases. Yamaguchi, K., Chijiiwa, K., Noshiro, H., Torata, N., Kinoshita, M., Tanaka, M. Hepatogastroenterology (1999) [Pubmed]
  20. Induction of cystine transport via system x-c and maintenance of intracellular glutathione levels in pancreatic acinar and islet cell lines. Sato, H., Kuriyama-Matsumura, K., Siow, R.C., Ishii, T., Bannai, S., Mann, G.E. Biochim. Biophys. Acta (1998) [Pubmed]
  21. Radioimmunoassay of lactoferrin in pancreatic juice as a test for pancreatic diseases. Fedail, S.S., Harvey, R.F., Salmon, P.R., Read, A.E. Lancet (1978) [Pubmed]
  22. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Abraham, S.C., Cruz-Correa, M., Argani, P., Furth, E.E., Hruban, R.H., Boitnott, J.K. Am. J. Surg. Pathol. (2003) [Pubmed]
  23. Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion into rat pancreatic ducts. Puig-Diví, V., Molero, X., Salas, A., Guarner, F., Guarner, L., Malagelada, J.R. Pancreas (1996) [Pubmed]
  24. Ampicillin concentrations in pancreatic fluid bile obtained at endoscopic retrograde cholangiopancreatography (ERCP). Roberts, E.A., Williams, R.J. Scand. J. Gastroenterol. (1979) [Pubmed]
  25. Gastric secretion of acid in patients with pancreatic disease. Saunders, J.H., Cargill, J.M., Wormsley, K.G. Digestion (1978) [Pubmed]
  26. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Lee, J.H., Choi, J.H., Namkung, W., Hanrahan, J.W., Chang, J., Song, S.Y., Park, S.W., Kim, D.S., Yoon, J.H., Suh, Y., Jang, I.J., Nam, J.H., Kim, S.J., Cho, M.O., Lee, J.E., Kim, K.H., Lee, M.G. Hum. Mol. Genet. (2003) [Pubmed]
  27. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Kukor, Z., Tóth, M., Sahin-Tóth, M. Eur. J. Biochem. (2003) [Pubmed]
  28. Human serum alpha 1-antichymotrypsin is an inhibitor of pancreatic elastases. Laine, A., Davril, M., Rabaud, M., Vercaigne-Marko, D., Hayem, A. Eur. J. Biochem. (1985) [Pubmed]
  29. Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer. Nakamura, H., Bai, J., Nishinaka, Y., Ueda, S., Sasada, T., Ohshio, G., Imamura, M., Takabayashi, A., Yamaoka, Y., Yodoi, J. Cancer Detect. Prev. (2000) [Pubmed]
  30. Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines. Blanchard, J.A., Barve, S., Joshi-Barve, S., Talwalker, R., Gates, L.K. Dig. Dis. Sci. (2001) [Pubmed]
  31. Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases. Kubota, K., Som, P., Brill, A.B., Sacker, D.F., Meinken, G.E., Srivastava, S.C., Atkins, H.L. J. Nucl. Med. (1989) [Pubmed]
  32. Total pancreatectomy in the MEN-1 syndrome. Tisell, L.E., Ahlman, H., Jansson, S., Grimelius, L. The British journal of surgery. (1988) [Pubmed]
  33. Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Parks, R.W., Bettschart, V., Frame, S., Stockton, D.L., Brewster, D.H., Garden, O.J. Br. J. Cancer (2004) [Pubmed]
  34. Enzyme immunoassay for pancreatic lipase: comparison with turbidimetric method in pancreatic diseases. Rizzotti, P., Dechecchi, C., Zanchetta, M., Zaninotto, M., Plebani, M., Burlina, A. Clin. Biochem. (1985) [Pubmed]
  35. A comparison between injection and infusion of pancreatic stimulants in the diagnosis of exocrine pancreatic insufficiency. Gullo, L., Costa, P.L., Labò, G. Digestion (1978) [Pubmed]
WikiGenes - Universities